FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048802245> ?p ?o ?g. }

• W3048802245 endingPage "85" @default.
• W3048802245 startingPage "79" @default.
• W3048802245 abstract "Optimizing the induction therapy of acute myeloid leukemia (AML) may improve the remission rate and reduce the risk of relapse, thereby extend survival. Cyclophosphamide (CTX) shows benefit in treating relapsed and refractory AML patients, but it has not been reported in first-line induction regimens. To assess the efficacy and safety of CTX and moderate-dosage cytarabine (Ara-C) as induction chemotherapy in newly diagnosed adult AML, 40 patients were enrolled to receive CTX (20 mg/kg/d) for 4 consecutive days and Ara-C for 3 (1 g/m2 q12h, CA4+3) or 5 (1 g/m2 qd, CA4+5) days. With one course of induction chemotherapy, the overall response rate and the complete remission rate (CR) was 82.5% (33/40) and 77.5% (31/40), respectively. The expected 5 years overall survival and relapse-free survival was 64% in patients experienced CR and fulfilled consolidation therapy. The neutrophil and platelet recovery time were 17 (range, 10-20) days and 16.5 (range, 12-30) days in the CA4+3 group, faster than that of 20 (16-36) days and 20 (14-36) days in the CA4+5 group (P = .006 and P = .006). The cyclophosphamide and cytarabine (CA) regimen was generally safe and had reversible adverse effects. The patients who failed to respond to the CA regimen did not benefit from a second course of other traditional induction chemotherapy either. In conclusion, the combined regimen of CTX and Ara-C represents a promising therapeutic approach to induce the first CR of newly diagnosed adult AML." @default.
• W3048802245 created "2020-08-18" @default.
• W3048802245 creator A5011159160 @default.
• W3048802245 creator A5035727375 @default.
• W3048802245 creator A5038043708 @default.
• W3048802245 creator A5069323001 @default.
• W3048802245 creator A5079732533 @default.
• W3048802245 creator A5088004444 @default.
• W3048802245 creator A5090999874 @default.
• W3048802245 date "2020-07-01" @default.
• W3048802245 modified "2023-10-07" @default.
• W3048802245 title "Combination of cyclophosphamide and cytarabine as induction regimen for newly diagnosed adult acute myeloid leukemia" @default.
• W3048802245 cites W1492445977 @default.
• W3048802245 cites W1519562949 @default.
• W3048802245 cites W1983994230 @default.
• W3048802245 cites W1993862617 @default.
• W3048802245 cites W2025086811 @default.
• W3048802245 cites W2042003714 @default.
• W3048802245 cites W2069448515 @default.
• W3048802245 cites W2074425311 @default.
• W3048802245 cites W2083386580 @default.
• W3048802245 cites W2097576978 @default.
• W3048802245 cites W2117844516 @default.
• W3048802245 cites W2118693086 @default.
• W3048802245 cites W2137881702 @default.
• W3048802245 cites W2139717439 @default.
• W3048802245 cites W2142830602 @default.
• W3048802245 cites W2148883973 @default.
• W3048802245 cites W2160746673 @default.
• W3048802245 cites W2174321851 @default.
• W3048802245 cites W2318674152 @default.
• W3048802245 cites W2339658711 @default.
• W3048802245 cites W2559537906 @default.
• W3048802245 cites W2570618306 @default.
• W3048802245 cites W2693515056 @default.
• W3048802245 cites W2766883662 @default.
• W3048802245 cites W2769885694 @default.
• W3048802245 cites W2774161211 @default.
• W3048802245 cites W2867994608 @default.
• W3048802245 doi "https://doi.org/10.1002/jha2.76" @default.
• W3048802245 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35847688" @default.
• W3048802245 hasPublicationYear "2020" @default.
• W3048802245 type Work @default.
• W3048802245 sameAs 3048802245 @default.
• W3048802245 citedByCount "2" @default.
• W3048802245 countsByYear W30488022452022 @default.
• W3048802245 countsByYear W30488022452023 @default.
• W3048802245 crossrefType "journal-article" @default.
• W3048802245 hasAuthorship W3048802245A5011159160 @default.
• W3048802245 hasAuthorship W3048802245A5035727375 @default.
• W3048802245 hasAuthorship W3048802245A5038043708 @default.
• W3048802245 hasAuthorship W3048802245A5069323001 @default.
• W3048802245 hasAuthorship W3048802245A5079732533 @default.
• W3048802245 hasAuthorship W3048802245A5088004444 @default.
• W3048802245 hasAuthorship W3048802245A5090999874 @default.
• W3048802245 hasBestOaLocation W30488022451 @default.
• W3048802245 hasConcept C126322002 @default.
• W3048802245 hasConcept C141071460 @default.
• W3048802245 hasConcept C142424586 @default.
• W3048802245 hasConcept C143998085 @default.
• W3048802245 hasConcept C197934379 @default.
• W3048802245 hasConcept C2776611710 @default.
• W3048802245 hasConcept C2776694085 @default.
• W3048802245 hasConcept C2776755627 @default.
• W3048802245 hasConcept C2778041864 @default.
• W3048802245 hasConcept C2778729363 @default.
• W3048802245 hasConcept C2781413609 @default.
• W3048802245 hasConcept C71924100 @default.
• W3048802245 hasConcept C86803240 @default.
• W3048802245 hasConcept C87355193 @default.
• W3048802245 hasConcept C90924648 @default.
• W3048802245 hasConceptScore W3048802245C126322002 @default.
• W3048802245 hasConceptScore W3048802245C141071460 @default.
• W3048802245 hasConceptScore W3048802245C142424586 @default.
• W3048802245 hasConceptScore W3048802245C143998085 @default.
• W3048802245 hasConceptScore W3048802245C197934379 @default.
• W3048802245 hasConceptScore W3048802245C2776611710 @default.
• W3048802245 hasConceptScore W3048802245C2776694085 @default.
• W3048802245 hasConceptScore W3048802245C2776755627 @default.
• W3048802245 hasConceptScore W3048802245C2778041864 @default.
• W3048802245 hasConceptScore W3048802245C2778729363 @default.
• W3048802245 hasConceptScore W3048802245C2781413609 @default.
• W3048802245 hasConceptScore W3048802245C71924100 @default.
• W3048802245 hasConceptScore W3048802245C86803240 @default.
• W3048802245 hasConceptScore W3048802245C87355193 @default.
• W3048802245 hasConceptScore W3048802245C90924648 @default.
• W3048802245 hasIssue "1" @default.
• W3048802245 hasLocation W30488022451 @default.
• W3048802245 hasLocation W30488022452 @default.
• W3048802245 hasLocation W30488022453 @default.
• W3048802245 hasOpenAccess W3048802245 @default.
• W3048802245 hasPrimaryLocation W30488022451 @default.
• W3048802245 hasRelatedWork W1971347970 @default.
• W3048802245 hasRelatedWork W2034612532 @default.
• W3048802245 hasRelatedWork W2294565310 @default.
• W3048802245 hasRelatedWork W2380296678 @default.
• W3048802245 hasRelatedWork W2383638159 @default.
• W3048802245 hasRelatedWork W2409484189 @default.

• next